medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2014, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2014; 30 (4)

Ethics and radiological protection in nuclear medicine in hematology

Language: Spanish
References: 32
Page: 319-331
PDF size: 129.28 Kb.


ABSTRACT

The increasingly width of the field of radioactive substances use in medicine demands the managing and the application of ethics principles in a very close relation to radiological protection. There is an unavoidable need to take ethics perspective in the use of ionizing radiations and the radiological protection of the patient to the practice of Nuclear Medicine in Hematology (NMH). This must not be assumed as a process of simple adoption, but as the creative application of his principles. It will be highly useful to continue including in the teaching programs aimed to professionals who use nuclear medicine as a diagnostic or therapeutic tool, a scientific formation based on the ethics principles including the elements of radiological protection. The multidisciplinary group dedicated to NMH has a moral and ethical responsibility to guarantee the appropriate use of radioactive substances in the medical technology and scientific development of this specialty. The following review on the subject wishes to contribute to the promotion of ethical principles in hematology specialists during their daily work. With the application of ethics in the context of NMH, we will also improve the radiological protection of our patients which will contribute to their best care and will increase the quality of our work.


REFERENCES

  1. Instituto de Investigación y Desarrollo, Academia Nacional de Ciencias de Buenos Aires. Una visión científica de la radioactividad desde su descubrimiento hasta nuestros días. Buenos Aires: Academia Nacional de Ciencias de Buenos Aires. 2009.(visitado: Noviembre 25, 2013) Disponible en: http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/44/104/44104791.pdf

  2. Faulkner, K. Ethical concerns arising from screening procedures such as mammography and self-referral. Radiat Prot Dosimetry 2009;135(2):90-4. doi: 10.1093/rpd/ncp012.

  3. Persson L, Shrader-Frechette K. An evaluation of the ethical principles of the ICRP's radiation protection standards for workers. Health Phys. 2001 Mar;80(3):225-34.

  4. Colectivo de autores: Efectos biológicos de las radiaciones ionizantes. En: Protección radiológica en la aplicación de las técnicas nucleares. La Habana: Centro de Información de la Energía. 1999; p.11-8.

  5. ICRP 2013: 2nd International Symposium on the System of Radiological Protection. October 22 - 24, 2013 - Abu Dhabi, UAE. Symposium Summary. Disponible en: http://www.icrp.org/docs/Summary of ICRP 2013 Symposium.pdf [consultado: Noviembre 27, 2013]

  6. Doerr W. The biology of tissue reactions. En: ICRP 2013: 2nd International Symposium on the System of Radiological Protection. October 22 - 24, 2013 - Abu Dhabi, UAE. Disponible en: http://www.icrp.org/docs/ ICRP abstract document.pdf [consultado: Noviembre 27, 2013]

  7. Miyazaki S. General Tissue Reactions and Implications for Radiation Protection. En: ICRP 2013: 2nd International Symposium on the System of Radiological Protection. October 22 - 24, 2013 - Abu Dhabi, UAE .Disponible en: http://www.icrp.org/docs/Shinichiro Miyazaki General Tissue Reactions and Implications for Radiation Protection.pdf [consultado: Noviembre 27, 2013]

  8. Lazo T. Non-Cancer Effects: Science and Values Aspects of Protection Decisions. En: ICRP 2013: 2nd International Symposium on the System of Radiological Protection. October 22 - 24, 2013 - Abu Dhabi, UAE. Disponible en:http://www.icrp.org/docs/Ted Lazo Non-Cancer Effects Science and Values Aspects of Protection Decisions.pdf [consultado: Noviembre 27, 2013]

  9. Powsner ER. Applications of nuclear medicine in hematology. En Bick RL ed. Hematology Clinical and Laboratory Practice. St. Louis: Mosby, 1993:91-120.

  10. Sheikh TH. The journey: from X-rays to PET-MRI. Indian J Nucl Med 2010;25(3): 124-5.

  11. Putínseva E, Fundora T, Fernández N, Figueredo M. Desarrollo y aplicación de las técnicas de medicina nuclear y métodos biológicos en hematología. Experiencia de 30 años en el Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter 1996;12(2):130-4.

  12. Fundora T, Fernández N, Gautier H, Macías C, del Valle L, Martínez G et al. Aplicación de la medicina nuclear en el Instituto de Hematología e Inmunología: Resultados más relevantes. Rev Cubana Hematol Inmunol Hemoter [revista en la Internet]. 2004 Ago [citado 2013 Nov 26] ; 20(2): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892004000200001&lng=es

  13. Resolución Conjunta CITMA-MINSAP " Normas Básicas de Seguridad Radiologicas". Gaceta Oficial de la República de Cuba del 30 de Noviembre de 2001.

  14. Centro Nacional de Seguridad Nuclear. Guía de Seguridad para la práctica de Medicina Nuclear. Revisión 01/11. La Habana: CUBAENERGIA, 2011.

  15. INTERNATIONAL ATOMIC ENERGY AGENCY, Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards - Interim Edition, General Safety Requirements Part 3, IAEA, Vienna, 2011.

  16. Hamed MI. Code of practice for radiation protection in nuclear medicine. [dissertation]. Sudan: Sudan Academy of Sciences Atomic Energy Council; 2010. Disponible en: http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/41/122/41122234.p df [consultado: Noviembre 27, 2013]

  17. Malone J, Guleria R, Craven C, Horton P, Jarvinen H, Mayo J. Justification of diagnostic medical exposures: some practical issues. Report of an International Atomic Energy Agency Consultation. Br J Radiol 2012;85: 523–38.

  18. Pérez M. Referral Criteria and Clinical Decision Support: Radiological Protection Aspects for Justification . En: ICRP 2013: 2nd International Symposium on the System of Radiological Protection. October 22 - 24, 2013 - Abu Dhabi, UAE. Disponible en: http://www.icrp.org/docs/ ICRP abstract document.pdf [consultado: Noviembre 27, 2013]

  19. Najean Y. Is a clinical consensus possible for the polycythaemic patients? Nov Rev Fr Hematol.1994;36:141-3.

  20. Ferrant A. What clinical and laboratory data are indicative of polycythemia and when are blood volumes studies needed? Nouv Rev Fr Hematol.1994;36:151-4.

  21. Fernández N, Fundora T, Macías I. Policitemia Vera. Experiencias en el diagnóstico y tratamiento en el Instituto de Hematología e Inmunología: Experiences in diagnosis and treatment in the Institute of Hematology and Immunology. Rev Cubana Hematol Inmunol Hemoter [revista en la Internet]. 2011 Mar [citado 2013 Dic 04] ; 27(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892011000100007&lng=es.

  22. Fernández N, Fundora T, Milanés MT. Fósforo 32: Experiencia de 30 años en la policitemia vera. Rev Cubana Hematol Inmunol Hemoter [revista en la Internet]. 2003 Dic [citado 2013 Nov 28]; 19(2-3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892003000200013&lng=es .

  23. López L. La ética del científico. Mínimo enfoque de un gran problema. En: Colectivos de Autores del GESOCYT. Problemas Sociales de la Ciencia y la Tecnología. La Habana: Félix Varela, 1994. p.167-83.

  24. Avadanei C,Rosca-Fartat G, Stanescu G. Practitioners education on medical exposure justification. Radiat Prot Dosimetry 2011;147(1-2):346-8. doi: 10.1093/rpd/ncr332.

  25. INTERNATIONAL ATOMIC ENERGY AGENCY. El físico médico: Criterios y recomendaciones para su formación académica, entrenamiento clínico y certificación en América Latina. Human Health Reports No. 1. Vienna:IAEA; 2010.

  26. Postgraduate Medical Physics Academic Programmes. Endorsed by the International Organization for Medical Physics (IOMP). Training Course Series; no. 56; Dec 2013. Disponible en: http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/45/008/45008724.p df [consultado: Noviembre 27, 2013]

  27. Clinical Training of Medical Physicists Specializing in Nuclear Medicine. Training Course Series; no. 50; May 2011. Disponible en: http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/42/081/42081556.p df [consultado: Noviembre 27, 2013]

  28. Schreiner-Karoussou, A. Review of existing issues, ethics and practices in general medical research and in radiation protection research. Radiat Protect Dosimetry. 2008;129(1-3):303-6.

  29. Japan Radioisotope Association, Medical Science and Pharmaceutical Committee, Tokyo (Japan); Japanese Society of Nuclear Medicine, Radiation Protection Committee, Tokyo (Japan). Current status and future prospect of radiation exposure to research volunteers in institutes with nuclear medicine. The report of questionnaires regarding radiation exposures to volunteers in clinical researches and clinical trials. Radioisotopes (Tokyo) 2010;59(11):659-73.

  30. Kurihara C. Ethical and social implications of microdosing clinical trial (3). Radiological protection of human subjects in research. Hoshasen Kagaku 2008;51(3):28-35.

  31. Sia S, Chhem RK, Czarwinski R. Radiation protection: Some philosophical and ethical issues. Eur J Radiol. 2010; 76(1):3-5. doi: 10.1016/j.ejrad.2010.06.030.

  32. Medford Cárdenas M, Ordoñez Povea B, Garzó Rueda RL, Carrazana García D. Ética en la ciencia y tecnología. Un enfoque desde la educación médica superior. Rev méd electrón[Seriada en línea] 2010;32(1). Disponible en URL: http://www.revmatanzas.sld.cu/revista%20medica/ano%202010/vol6%202010/te ma08.htm [consultado: Noviembre 27, 2013]




2020     |     www.medigraphic.com